Maximus, Inc. (MMS) Stock Analysis and Metrics

Maximus

NYSE: MMS

$59.65 ▲ +2.24 (+3.90%)

At close: Jul 24, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap3.23 Bn

P/E8.67

P/S0.61

Div. Yield0.02

ROIC (Qtr)0.02

Total Debt (Qtr)1.54 Bn

Revenue Growth (1y) (Qtr)-4.10

Add ratio to table…

About

Maximus is a leading provider of tech-enabled services to government agencies, specializing in program operations, clinical services, and advanced technology solutions. The company helps governments improve public service delivery for over 100 million citizens in the U. S., U. K., Canada, and the Middle East by translating public policy into scalable operating models. Maximus focuses on health, human services, and employment programs, leveraging automation, artificial intelligence, and data analytics to enhance efficiency and outcomes. Its solutions address complex challenges in eligibility, enrollment, customer service, and system modernization for federal, state, and international governments.

Maximus generates revenue through a mix of performance-based, cost-plus, fixed price, and time-and-materials contracts. Performance-based contracts, which account for a significant portion of its revenue, are tied to metrics such as call volumes, assessments, or enrollments. The company also earns revenue from clinical services, including medical disability examinations and eligibility assessments, as well as technology modernization projects for government agencies. Its customer base primarily consists of U. S. federal and state agencies, with additional contracts in international markets, particularly in health and employment services.

The company operates through the following segments:

• U. S. Federal Services: This segment, contributing 56% of total revenue in fiscal year 2025, delivers program operations, clinical services, and technology solutions to U. S. federal agencies. Key activities include managing contact centers for Medicare and the Affordable Care Act marketplace, supporting student loan borrowers, and conducting medical disability examinations for the Department of Veterans Affairs. The segment also provides cybersecurity, cloud infrastructure, and AI-driven analytics to modernize government systems.

• U. S. Services: Generating 32% of total revenue, this segment serves state and local governments with program operations, clinical assessments, and employment services. It supports Medicaid, Children’s Health Insurance Program (CHIP), and Temporary Assistance to Needy Families (TANF) programs through eligibility assistance, enrollment services, and job readiness initiatives. The segment also offers technology solutions, including system implementation and independent verification and validation services.

• Outside the U. S.: Accounting for 11% of revenue, this segment provides business process services and employment solutions to international governments. It conducts health and disability assessments, delivers digitally enabled customer services, and supports employment programs in the U. K., Canada, and the Middle East. Recent divestitures have streamlined operations to reduce volatility in this segment.

Maximus holds a strong position in the government services industry, competing with firms like General Dynamics Information Technology, Deloitte, Leidos, and Accenture in the U. S. federal market. In state and local markets, it faces competition from Conduent, Acentra Health, and Public Consulting Group, as well as government insourced operations. Internationally, competitors include Atos, Capita, and Serco. The company’s competitive advantages include deep subject matter expertise, financial strength with access to a $750 million credit line, and a proven track record in securing and executing government contracts. Its ability to integrate technology with program administration further differentiates it from peers.

Maximus serves a diverse customer base, primarily government agencies at the federal, state, and international levels. Key customers include the Centers for Medicare and Medicaid Services (CMS), the U. S. Department of Veterans Affairs, the Department for Work and Pensions in the U. K., and various state Medicaid and employment programs. The company’s services extend to supporting beneficiaries of health insurance marketplaces, student loan borrowers, and job seekers transitioning to employment.

Investment Thesis

▲ Bull case

Maximus is positioned to capitalize on a structural shift in government contracting toward technology-driven program integrity solutions, where its early investments in AI-enabled automation are creating sustainable operating leverage that the market is underestimating. The company's Total Experience Management (TXM) solution has been recognized by a federal agency as the most sophisticated AI deployment in a contact center environment, signaling strong differentiation in a multi-billion-dollar market. This is not merely incremental improvement but a foundational shift where AI is being embedded into core workflows to reduce fraud upfront, improve service delivery, and increase scale without proportional labor cost increases—directly addressing government priorities around efficiency and trust. The fact that Maximus is acting as "customer zero" for these initiatives allows it to refine governance, controls, and integration methodologies in real-world settings, de-risking future scalability and enhancing its ability to win new work and rebids through proven, trusted execution. These advantages are particularly potent in the U.S. Federal Services segment, where larger contract scales amplify the margin impact of technology investments, and where the company has already raised its full-year operating margin guidance to 17.5% based on demonstrated durability from automation. The market appears to be focusing on near-term revenue volatility from tough comparables and DSO timing, while overlooking how these technology-driven efficiency gains are becoming self-reinforcing and less dependent on volume fluctuations, supporting the company's raised near-term adjusted EBITDA margin target range of 12% to 15%—a significant uplift from the historical 10% to 13% range just 18 months ago.
The H.R. 1 (Working Families Tax Cut Act) opportunity represents a hidden catalyst that management did not heavily promote but which could drive meaningful reacceleration in the U.S. Services segment starting in Q4 FY26 and into FY27. Bruce Caswell explicitly noted that one state opportunity utilizing existing contracts could drive a more than 30% increase in current program revenue, subject to final scope and implementation timing—a figure that is material given the segment's $416 million Q2 revenue base. This is not speculative; the company has moved beyond concept into serious implementation planning with state customers, as evidenced by senior officials praising the Accuracy Assistant tool as the only truly end-to-end complete vendor solution they have seen for SNAP payment error reduction. The pipeline for H.R. 1-related opportunities increased 75% quarter-over-quarter, and management forecasts mid-single-digit organic growth in U.S. Services for Q4 FY26, providing early momentum as the company enters FY27. Crucially, these opportunities are tied to bipartisan policy trends around work requirements and program integrity, reducing political risk, and Maximus's focus on maintaining public trust through responsible AI deployment—such as using intelligent document processing to verify work compliance while preserving beneficiary appeal rights—aligns perfectly with state customers' cautious adoption stance. The market is likely underestimating both the near-term conversion rate of this pipeline and the potential for these solutions to become recurring revenue streams as more states adopt similar frameworks, especially given the company's disciplined approach to integration, pricing, and change management.
Maximus's capital allocation strategy reflects a disciplined, value-accretive approach that the market is ignoring amid its focus on near-term earnings volatility. The company has consistently repurchased shares when it believes the stock does not reflect intrinsic value, as demonstrated by the $111 million in Q2 repurchases and the subsequent $40 million through May 1, followed by a Board-authorized $400 million refresh of the repurchase program effective May 11. This is not opportunistic buybacks for EPS dilution mitigation but a strategic deployment of excess cash flow grounded in a conservative assessment of intrinsic value, supported by a net leverage ratio of 1.8x—well below the target range of 2x to 3x—providing ample capacity for both buybacks and selective M&A. Management explicitly stated they remain focused on acquisition targets that add capabilities, expand customer relationships, and create revenue synergies in federal, defense, and national security domains, requiring valuations to be reasonable and expected returns to exceed the cost of capital. With free cash flow guidance reiterated at $450 million to $500 million for FY26 and DSO expected to finish below 70 days, the company is positioned to generate substantial excess cash flow even after funding organic investments. The market's preoccupation with quarterly DSO fluctuations and tough comparables obscures the long-term value creation from this capital discipline, which compounds over time through reduced share count and strategic reinvestment, particularly as the company scales its AI and automation advantages across higher-margin federal contracts.

Maximus is positioned to capitalize on a structural shift in government contracting toward technology-driven program integrity solutions, where its early investments in AI-enabled automation are creating sustainable operating leverage that the market is underestimating. The company's Total Experience Management (TXM) solution has been recognized by a federal agency as the most sophisticated AI deployment in a contact center environment, signaling strong differentiation in a multi-billion-dollar market. This is not merely incremental improvement but a foundational shift where AI is being embedded into core workflows to reduce fraud upfront, improve service delivery, and increase scale without proportional labor cost increases—directly addressing government priorities around efficiency and trust. The fact that Maximus is acting as "customer zero" for these initiatives allows it to refine governance, controls, and integration methodologies in real-world settings, de-risking future scalability and enhancing its ability to win new work and rebids through proven, trusted execution. These advantages are particularly potent in the U.S. Federal Services segment, where larger contract scales amplify the margin impact of technology investments, and where the company has already raised its full-year operating margin guidance to 17.5% based on demonstrated durability from automation. The market appears to be focusing on near-term revenue volatility from tough comparables and DSO timing, while overlooking how these technology-driven efficiency gains are becoming self-reinforcing and less dependent on volume fluctuations, supporting the company's raised near-term adjusted EBITDA margin target range of 12% to 15%—a significant uplift from the historical 10% to 13% range just 18 months ago.
The H.R. 1 (Working Families Tax Cut Act) opportunity represents a hidden catalyst that management did not heavily promote but which could drive meaningful reacceleration in the U.S. Services segment starting in Q4 FY26 and into FY27. Bruce Caswell explicitly noted that one state opportunity utilizing existing contracts could drive a more than 30% increase in current program revenue, subject to final scope and implementation timing—a figure that is material given the segment's $416 million Q2 revenue base. This is not speculative; the company has moved beyond concept into serious implementation planning with state customers, as evidenced by senior officials praising the Accuracy Assistant tool as the only truly end-to-end complete vendor solution they have seen for SNAP payment error reduction. The pipeline for H.R. 1-related opportunities increased 75% quarter-over-quarter, and management forecasts mid-single-digit organic growth in U.S. Services for Q4 FY26, providing early momentum as the company enters FY27. Crucially, these opportunities are tied to bipartisan policy trends around work requirements and program integrity, reducing political risk, and Maximus's focus on maintaining public trust through responsible AI deployment—such as using intelligent document processing to verify work compliance while preserving beneficiary appeal rights—aligns perfectly with state customers' cautious adoption stance. The market is likely underestimating both the near-term conversion rate of this pipeline and the potential for these solutions to become recurring revenue streams as more states adopt similar frameworks, especially given the company's disciplined approach to integration, pricing, and change management.
Maximus's capital allocation strategy reflects a disciplined, value-accretive approach that the market is ignoring amid its focus on near-term earnings volatility. The company has consistently repurchased shares when it believes the stock does not reflect intrinsic value, as demonstrated by the $111 million in Q2 repurchases and the subsequent $40 million through May 1, followed by a Board-authorized $400 million refresh of the repurchase program effective May 11. This is not opportunistic buybacks for EPS dilution mitigation but a strategic deployment of excess cash flow grounded in a conservative assessment of intrinsic value, supported by a net leverage ratio of 1.8x—well below the target range of 2x to 3x—providing ample capacity for both buybacks and selective M&A. Management explicitly stated they remain focused on acquisition targets that add capabilities, expand customer relationships, and create revenue synergies in federal, defense, and national security domains, requiring valuations to be reasonable and expected returns to exceed the cost of capital. With free cash flow guidance reiterated at $450 million to $500 million for FY26 and DSO expected to finish below 70 days, the company is positioned to generate substantial excess cash flow even after funding organic investments. The market's preoccupation with quarterly DSO fluctuations and tough comparables obscures the long-term value creation from this capital discipline, which compounds over time through reduced share count and strategic reinvestment, particularly as the company scales its AI and automation advantages across higher-margin federal contracts.

▼ Bear case

Maximus faces significant near-term headwinds from tough year-over-year comparisons that are being underestimated in their duration and impact, particularly in the U.S. Services segment where revenue declines are not merely temporary but may reflect deeper structural challenges in state-level program adoption. The company acknowledged that U.S. Services revenue of $416 million in Q2 FY26 was down from $442 million in the prior year, with management attributing part of the prior-year strength to temporary clinical volume surges and state-specific dynamics in larger clinical contracts—not broader trends. While they express confidence in a return to growth by Q4 FY26 driven by H.R. 1-related activities, this optimism may be premature given the complexity of state-level implementation, including the patchwork quilt of regulations Bruce Caswell cited as a barrier to AI and automation adoption. States have limited bandwidth and budget resources, especially while implementing H.R. 1, making "system surgery" for significant automation a low priority. The segment's operating margin of 9.3% in Q2 FY26 (10.9% excluding the $6.9 million asset impairment) remains well below the U.S. Federal Services segment's 17.6%, and the company's full-year outlook of approximately 10.0% reflects ongoing pressure from integration challenges with state legacy systems, workforce retraining needs, and customer caution around public trust—factors that are not easily overcome by technology alone. The market may be assuming a rapid re-acceleration in U.S. Services that fails to account for the lengthy sales cycles, regulatory approvals, and change management required in state government, potentially overestimating the near-term contribution of the H.R. 1 pipeline.
The company's reliance on a single major federal customer for DSO dynamics creates a material and recurring liquidity risk that the market is ignoring, despite management's assurances about eventual collections. DSO remained elevated at 78 days at March 31, 2026, unchanged from December 31, 2025, driven by ongoing administrative delays at this customer, which has extremely complex and data-intensive invoicing requirements, including retroactive changes requiring rework of prior period invoices. While Maximus expresses confidence that outstanding invoices will be collected due to the funded nature of the contract, the customer's accounts receivable increased in Q2 and may remain flat in Q3 before declining in Q4—a pattern that suggests persistent friction in the invoicing and collections process. The company expanded its receivables purchase agreement ceiling from $250 million to $350 million as a low-cost liquidity tool, but this does not address the root cause of delays. If administrative delays persist or worsen due to evolving requirements, staffing shortages, or systemic inefficiencies at the federal agency, DSO could remain elevated beyond management's expectations, constraining free cash flow conversion and forcing continued reliance on costly short-term financing or further reductions in share repurchases. The market may be assuming a smooth Q4 rebound in collections based on historical patterns, but the increasing complexity of federal invoicing requirements—particularly around retroactive adjustments—could make this a structural issue rather than a temporary one, undermining the cash flow stability needed to support the company's capital deployment priorities.
Maximus's aggressive share repurchase program, while supported by a low leverage ratio, risks overextending the company's financial flexibility in the face of uncertain M&A opportunities and potential economic headwinds, a risk the market is overlooking. The company repurchased approximately 1.4 million shares for $111 million in Q2 and an additional 600 thousand shares for $40 million through May 1, followed by a $400 million refresh of the authorization—totaling up to $551 million in potential repurchases. While management emphasizes discipline in targeting acquisitions that exceed the cost of capital and require reasonable valuations, the federal, defense, and national security focus they cite may limit the available target universe, increasing the risk of overpaying for strategic fits or facing prolonged search periods. With interest expense estimated at $84 million for FY26 and a net leverage ratio of 1.8x, the company has room to maneuver, but a downturn in government spending—particularly if economic conditions reduce demand for safety-net programs like SNAP and unemployment insurance, which Maximus administers—could pressure revenues and cash flow generation. The Outside the U.S. segment already reported an operating loss of $3.1 million in Q2 FY26, and while management anticipates breakeven for the full year, any prolonged weakness in international markets could further strain consolidated results. The market may be assuming that the company's strong pipeline and technology advantages will insulate it from macroeconomic shifts, but government contractors are not immune to budget cycles, and a prolonged period of reduced federal or state spending could force Maximus to choose between maintaining its repurchase pace and preserving liquidity for operational needs or acquisitions, potentially undermining both its growth and shareholder return objectives.

Maximus faces significant near-term headwinds from tough year-over-year comparisons that are being underestimated in their duration and impact, particularly in the U.S. Services segment where revenue declines are not merely temporary but may reflect deeper structural challenges in state-level program adoption. The company acknowledged that U.S. Services revenue of $416 million in Q2 FY26 was down from $442 million in the prior year, with management attributing part of the prior-year strength to temporary clinical volume surges and state-specific dynamics in larger clinical contracts—not broader trends. While they express confidence in a return to growth by Q4 FY26 driven by H.R. 1-related activities, this optimism may be premature given the complexity of state-level implementation, including the patchwork quilt of regulations Bruce Caswell cited as a barrier to AI and automation adoption. States have limited bandwidth and budget resources, especially while implementing H.R. 1, making "system surgery" for significant automation a low priority. The segment's operating margin of 9.3% in Q2 FY26 (10.9% excluding the $6.9 million asset impairment) remains well below the U.S. Federal Services segment's 17.6%, and the company's full-year outlook of approximately 10.0% reflects ongoing pressure from integration challenges with state legacy systems, workforce retraining needs, and customer caution around public trust—factors that are not easily overcome by technology alone. The market may be assuming a rapid re-acceleration in U.S. Services that fails to account for the lengthy sales cycles, regulatory approvals, and change management required in state government, potentially overestimating the near-term contribution of the H.R. 1 pipeline.
The company's reliance on a single major federal customer for DSO dynamics creates a material and recurring liquidity risk that the market is ignoring, despite management's assurances about eventual collections. DSO remained elevated at 78 days at March 31, 2026, unchanged from December 31, 2025, driven by ongoing administrative delays at this customer, which has extremely complex and data-intensive invoicing requirements, including retroactive changes requiring rework of prior period invoices. While Maximus expresses confidence that outstanding invoices will be collected due to the funded nature of the contract, the customer's accounts receivable increased in Q2 and may remain flat in Q3 before declining in Q4—a pattern that suggests persistent friction in the invoicing and collections process. The company expanded its receivables purchase agreement ceiling from $250 million to $350 million as a low-cost liquidity tool, but this does not address the root cause of delays. If administrative delays persist or worsen due to evolving requirements, staffing shortages, or systemic inefficiencies at the federal agency, DSO could remain elevated beyond management's expectations, constraining free cash flow conversion and forcing continued reliance on costly short-term financing or further reductions in share repurchases. The market may be assuming a smooth Q4 rebound in collections based on historical patterns, but the increasing complexity of federal invoicing requirements—particularly around retroactive adjustments—could make this a structural issue rather than a temporary one, undermining the cash flow stability needed to support the company's capital deployment priorities.
Maximus's aggressive share repurchase program, while supported by a low leverage ratio, risks overextending the company's financial flexibility in the face of uncertain M&A opportunities and potential economic headwinds, a risk the market is overlooking. The company repurchased approximately 1.4 million shares for $111 million in Q2 and an additional 600 thousand shares for $40 million through May 1, followed by a $400 million refresh of the authorization—totaling up to $551 million in potential repurchases. While management emphasizes discipline in targeting acquisitions that exceed the cost of capital and require reasonable valuations, the federal, defense, and national security focus they cite may limit the available target universe, increasing the risk of overpaying for strategic fits or facing prolonged search periods. With interest expense estimated at $84 million for FY26 and a net leverage ratio of 1.8x, the company has room to maneuver, but a downturn in government spending—particularly if economic conditions reduce demand for safety-net programs like SNAP and unemployment insurance, which Maximus administers—could pressure revenues and cash flow generation. The Outside the U.S. segment already reported an operating loss of $3.1 million in Q2 FY26, and while management anticipates breakeven for the full year, any prolonged weakness in international markets could further strain consolidated results. The market may be assuming that the company's strong pipeline and technology advantages will insulate it from macroeconomic shifts, but government contractors are not immune to budget cycles, and a prolonged period of reduced federal or state spending could force Maximus to choose between maintaining its repurchase pace and preserving liquidity for operational needs or acquisitions, potentially undermining both its growth and shareholder return objectives.

Customer Breakdown of Revenue (2025)

Peer Comparison

Companies in the Specialty Business Services

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	CTAS	Cintas Corp	82.43 Bn	0.00 Mn	0.00 Mn	2.66 Bn
2	RTO	Rentokil Initial Plc /Fi	71.81 Bn	0.00 Mn	0.00 Mn	5.57 Bn
3	RELX	Relx Plc	63.28 Bn	11.42 Mn	6.29 Mn	-
4	TRI	Thomson Reuters Corp /Can/	40.35 Bn	0.00 Mn	0.00 Mn	1.56 Bn
5	CPRT	Copart Inc	26.32 Bn	0.00 Mn	0.00 Mn	-
6	GPN	Global Payments Inc	22.09 Bn	0.00 Mn	0.00 Mn	22.57 Bn
7	RBA	Rb Global Inc.	20.79 Bn	0.00 Mn	0.00 Mn	2.32 Bn
8	ULS	UL Solutions Inc.	17.26 Bn	0.00 Mn	0.00 Mn	0.36 Bn

Research Tools

Developers

About

Investment Thesis

Segments Breakdown of Revenue (2025)

Customer Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Segments Breakdown of Revenue (2025)

Customer Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password